However, dysregulation of Egr1 is associated with hematological malignancies such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myelogenous leukemia (CML). This evidence concerns the gene EGR1 and chronic myelogenous leukemia, BCR-ABL1 positive.